Abstract
The development of in vitro assays of cell-mediated cytotoxicity has provided a means both of quantitating cell-mediated immunity (CMI) induced in vivo, and also of identifying thecytotoxic effector cells (CL) involved. Studies with the51 Cr release assay have clearly shown that a specific subpopulation of T lymphocytes (termed Tc-cytotoxic T lymphocytes) are responsible for mediating cytotoxicity in vitro, when cell preparations from animals undergoing allograft rejection or graft-versus-host reactions are assayed in vitro (Cerottini et al, 1970; Miller et al, 1971 ; Cerottini and Brunner, 1974). The Tc subpopu-lation has been further characterized in terms of cell-surface markers and is a distinct T-cell lineage of phenotype Ly-1 negative, Ly-2 positive, Ly-3 positive (Cantor and Boyse, 1976). Since cytotoxic T cells are, however, to be found in both Fc receptor-positive and-negative lymphocyte groups, some heterogeneity may still exist within the TC population (Stout et al., 1976). The results of in vitro assays of lymphoid cells from animals immunized with tumor cells have, however, been much less clear-cut, and the number of different effector cell types and the mechanisms of cytotoxicity have proliferated rapidly since the introduction of techniques for identifying different subpopulations of lymphocytes and mononuclear cells (Table I).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andrews, G. A., Congdon, C. C., Edwards, C. L., Gengozian, N., Nelson, S.,and Vodopick, H., 1967, Preliminary trials of clinical immunotherapy, Cancer Res. 27:2535.
Aoki, T., and Takahashi, T., 1972, Viral and cellular surface antigens of murine leukaemias and myelomas, J. Exp. Med. 135:443.
Aoki, T., Potter, M., and Sturm, M. M., 1973, Analysis by immunoelectron-microscopy of type-C viruses associated with primary and short-term transplanted mouse plasma cell tumors, J. Natl. Cancer Inst. 51:1609.
Armitage, P., 1971, Statistical Methods in Medical Research, Blackwell Scientific, Oxford. Aust, J. C, Jagarlamoody, S. D., and McKhann, C. F., 1970, Immunisation of lymphocytes in vitro for immunotherapy of malignant disease, Surg. Forum 21:118.
Bach, F. H., and Voynow, K. N., 1966, One way stimulation in mixed leukocyte cultures, Science 153:545.
Benacerraf, B., and McDevitt, H. O., 1972, Histocompatibility linked immune response genes, Science 175:273.
Bernstein, I. D., Wright, P. W., and Cohen, E., 1976, Generation of cytotoxic lymphocytes in vitro: Response of immune rat spleen cells to a syngeneic Gross-virus induced lymphoma in mixed lymphocyte-tumor culture, J. Immunol. 116:1367.
Bevan, M. J., 1975, The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens, J. Exp. Med. 142:1349.
Bevan, M. J., Epstein, R., and Cohn, M., 1974, The effect of 2-mercaptoethanol on murine mixed lymphocyte cultures, J. Exp. Med. 139:1025.
Bevan, M. J., Langman, R. E., and Cohn, M., 1976, H-2 antigen-specific cytotoxic T cells induced by conconavalin A: Estimation of their relative frequency, Eur. J. Immunol. 6:150.
Birch, J. M., Moore, M., and Craig, A. W., 1975, Cell surface antigen expression on chemically induced murine leukaemias, Brit. J. Cancer 31:630.
Blank, K. J., Freedman, H. A., and Lilly, F., 1976, T lymphocyte response to Friend virus-induced tumour cell Unes in mice of strains congenic at H-2, Nature 260:250.
Bowen, J. G., and Baldwin, R. W., 1975, Tumour-specific antigen related to rat histocompatibility antigens, Nature 258:75.
Brondz, B.D., Egorov, I. K., and Drizlikh, G.I., 1975, Private specificities of H-2K and H-2D loci as possible selective targets for effector lymphocytes in cell mediated immunity, J. Exp. Med. 141:11.
Broome, J. D., and Jeng, M. W., 1973, Promotion of replication in lymphoid cells by specific fluids and disulphides in vitro, J. Exp. Med. 138:574.
Bruce, J., Mitchison, N. A., and Shellam, G. R., 1976, Studies on a Gross-virus induced lymphoma in therat. III. Optomisation, specificity and applications of the in vitro immune response, Int. J. Cancer 17:342.
Brunner, K. T., Manel, J., Cerottini, J. C, and Chapins, B., 1968, Quantitative assay of the lytic action of immune lymphoid cells on 51Cr labelled allogeneic target cells, Immunology 14:181.
Brunner, K. T., Plata, F., Vasudevan, B. M., and Cerottini, J. C, 1975, in: Proceedings of the Fifth International Symposium of thePrincess Takamatsu Cancer Research Fund: Host Defence Against Cancer and Its Potentiation (D. Mizumo, G. Chihara, F. Fukuoka, T. Yamamoto, and Y. Yakamura, eds.), p. 43, University Park Press, Baltimore.
Burakoff, S. J., Germain, R. N., and Benacerraf, B., 1976, Inhibition of cell-mediated cytolysis of trinitrophenyl-derivatized target cells by alloantisera directed to theproducts of the K and D loci of theH-2 complex, Proc. Natl. Acad. Sci. U.S. 73:625.
Burton, R. C, and Warner, N. L., 1977a, Tumor immunity to murine plasma cell tumors. III. Detection of common tumor associated antigens on BALB/c, C3H and NZB plasma-cytomas by in vivo and in vitro induction of tumor immune responses, J. Natl. Cancer Inst. 58:709.
Burton, R. C., and Warner, N. L., 1977b, In vitro induction of tumor specific immunity. IV. Specific adoptive immunotherapy with cytotoxic T cells induced in vitro to plasma-cytoma antigens, Cancer Immunol. Immunother. 2:91.
Burton, R. C, and Warner, N. L., 1978a, In vitro induction of tumor specific immunity. V. Detection of common antigenic determinants of murine fibrosarcomas, Brit. J. Cancer (in press).
Burton, R. C., and Warner, N. L., 1978b, Tumor immunity to murine plasma cell tumors. IV. Influence of theresponder genotype on thespecificity of theimmune response to plasmacytomas and T lymphomas, Aust. J. Exp. Biol. Med. Sci. (in press).
Burton, R. C., and Warner, N. L., 1978c, Tumor immunity to murine plasma cell tumors. V. Genetic control of theprimary and secondary in vitro immune response to NZB plasma cell tumor antigens (submitted for publication).
Burton, R. C., Thompson, J., and Warner, N. L., 1975, In vitro induction of tumor specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes, J. Immunol. Methods 8:133.
Burton, R. C., Chism, S. E., and Warner, N. L., 1977a, In vitro induction of tumor specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens, J. Immunol 118:971.
Burton, R. C., Chism, S. E., and Warner, N. L., 1977b,In vitro induction of tumor specific immunity. VII. Does autosensitization occur with in vitro culture of T lymphocytes? J. Immunol. 119:1329.
Burton, R. C., Scott, D., and Warner, N. L., 1978, Failure to inhibit T cell mediated lysis of plasmacytomas by anti-H-2 sera (submitted for publication).
Cantor, H., and Boyse, E. A., 1975, Functional subclasses of T lymphocytes. 2. Cooperation between subclasses of Ly+ cells in generation of killer activity, J. Exp. Med. 141:1390.
Cantor, H., and Boyse, E. A., 1976, Regulation of cellular and humoral immune responses by T cell subclasses, Cold Spring Harbor Symp. Quant. Biol. 41:23.
Canty, T. G., and Wunderlich, J. R., 1971, Quantitative assessment of cellular and humoral responses to skin and tumor allografts, Transplantation 11:111.
Carnaud, C., Ilfeld, D., Brook, I., and Trainin, N., 1973, Increased reactivity of mouse spleen cells sensitised in vitro against syngeneic tumor cells in thepresence of a thymic humoralfactor, J. Exp. Med. 138:1521.
Carnaud, C., Ilfeld, D., Levo, Y., and Trainin, N., 1974, Enhancement of 3LL tumor growth by autosensitised T lymphocytes independent of thehost lymphatic system, Int. J. Cancer 14:168.
Cerottini, J. C., and Brunner, K. T., 1974, Cell mediated cytotoxicity, allograft rejection and tumor immunity, Adv. Immunol. 18:67.
Cerottini, J. C., Nordin, A. A., and Brunner, K. T., 1970, Specific in vitro cytotoxicity of thymus-derived lymphocytes sensitised to alloantigens, Nature 228:1308.
Chang, K. S. S., Law, L. W., and Appella, E., 1975, Distinction between tumor-specific transplantation antigen and virion antigens in solubilised products from membranes of virus-induced leukaemic cells, Int. J. Cancer 15:483.
Chism, S. E., Burton, R. C, and Warner, N. L., 1976, In vitro induction of tumor specific immunity. II. Activation of cytotoxic lymphocytes to murine oncofoetal antigens, J. Natl. Cancer Inst. 57:377.
Chism, S. E., Burton, R. C., Graill, D. L., Bell, P. M., and Warner, N. L., 1977, In vitro induction of tumor specific immunity. VI. Analysis of immune response by cellular competitive inhibition. Limitations and advantages of thetechnique, J. Immunol. Methods 16:245.
Cikes, M., Briberg, S., and Klein, G., 1973, Progressive loss of H-2 antigens with concomitant increase of cell surface antigens determined by Moloney leukaemia virus in cultured murine lymphomas, J. Natl. Cancer Inst. 50:347.
Clark, D. A., Phillips, R. A., and Miller, R. G., 1976, Characterisation of cells that suppress thecytotoxic activity of T lymphocytes. I. Quantitative measurement of inhibitor cells, J. Immunol. 116:1020.
Click, R. E., Benck, L., and Alter, B. J., 1972, Enhancement of antibody synthesis in vitro by mercaptoethanol, Cell. Immunol. 3:156.
Cohen, I. R., and Wekerle, H., 1973, Regulation of autosensitisation; theimmune activation and specific inhibition of self recognising thymus derived lymphocytes, J. Exp.Med. 137:224.
Cohen, I. R., Globerson, A., and Feldman, M., 1971, Autosensitisation in vitro, J. Exp.Med. 133:834.
Davidson, W. F., Pang, T., Banden, R. V., and Doherty, P. C., 1976, “Physiological interaction” does not explain theH-2 requirement for recognition of virus-infected cells by cytotoxic T cells, Aust. J. Exp. Biol Med. Sci. 54:413.
Davies, D. A. L., Baugh, V. S. G., Buckham, S., and Maustone, A. J., 1974, Separation ot thespecific antigen of a mouse lymphoma from histocompatibility antigens, Eur. J. Cancer 10:781.
Dennert, G., 1976, Thymus derived killer cells: Specificity of function and antigen recognition, Transplant. Rev. 29:59.
Doherty, P. C., and Zinkernagel, R. M., 1975, A biological role for themajor histocompatibility antigens, Lancet 1:1406.
Doherty, P.C., and Zinkernagel, R. M., 1976, Specific immune lysis of paramyxovirus-infected cells by H-2 compatible thymus-derived lymphocytes, Immunology 31:27.
Drapkin, M. S., Appella, E., and Law, L. W., 1974, Immunogenic properties of soluble tumor specific transplantation antigens induced by Simian virus 40, J. Natl. Cancer Inst. 52:259.
Dunkley, M., Miller, R. G., and Shortman, K., 1974, A modified 51Cr release assay for cytotoxic lymphocytes, J. Immunol. Methods 6:39.
Evans, B., Cox, H., and Alexander, P., 1973, Immunological specific activation of macrophages armed with thespecific macrophage arming factor (SMAF), Proc. Soc. Exp. Biol. (N. Y.) 143:256.
Fanger, M. W., Hart, D. A., Wells, J. V., and Nisonoff, A., 1970, Enhancement by reducing agents of thetransformation of human and rabbit periferal lymphocytes, J. Immunol. 105:1043.
Forman, J., and Britton, S., 1973, Cytotoxic potential of mouse spleen cells on H-2 antibody treated target cells, J. Exp. Med. 137:527.
Forni, G., and Green, I., 1976, Heterologous sera: A target for in vitro cell mediated cytotoxicity, J. Immunol. 116:1561.
Friend, K., Hellstrom, I., and Hellstrom, K.E., 1976, In vitro sensitisation to embryonic antigens, Int. J. Cancer 18:843.
Fujimoto, S., Chen, C. H., Sabbadini, E., and Sehon, A. H., 1973, Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice, J. Immunol. 111:1093.
Gale, R. P., and Zighelboim, J., 1975, Polymorphonuclear leukocytes in antibody-dependent cellular cy totoxicity, J. Immunol. 114:1047.
Gardner, I. D., Bowern, N. A., and Blanden, B. V., 1975, Cell mediated cytotoxicity against ectromelia virus-infected target cells. III. Role of the H-2 gene complex, Eur. J. Immunol 5:122.
Garrido, F., Schirrmacher, V., and Festenstein, H., 1976a, H-2-like specificities of foreign haplotypes appearing on a mouse sarcoma after vaccinia virus infection, Nature 259:228.
Garrido, F., Schirrmacher, V., and Festenstein, H., 1976b, Further evidence for derepression of H-2 and Ia-like specificities of foreign haplotypes in mouse tumour cells, Nature 261:705.
Germain, R. W., Dorf, M. E., and Benacerraf, B., 1975, Inhibition of T-lymphocyte mediated tumor specific lysis by alloantisera directed against the H-2 serological specificities of thetumor, J. Exp. Med. 142:1023.
Ginsberg, H., 1968, Graft versus host reaction in tissue culture. I. Lysis of monolayers of embryo mouse cells from strains differing in theH-2 histocompatibility locus by rat lymphocytes sensitised in vitro, Immunology 14:621.
Glaser, M., Lavrin, D., and Herberman, R. B., 1976a, In vivo protection against syngeneic cross virus induced lymphoma in rats: Comparison with in vitro studies of cell mediated immunity, J Immunol. 116:1507.
Glaser, M., Bonnard, G. D., and Herberman, R. B., 1976b, In vitro generation of secondary cell-mediated cytotoxic response against a syngeneic cross-virus-induced lymphoma in rats, J. Immunol. 116:430.
Golub, S. H., and Morton, D. L., 1974, Sensitisation of lymphocytes in vitro against human melanoma-associated antigens, Nature 251:161.
Golub, S. H., and Zielske, J., 1975, Induction of cell-mediated cytotoxic responses against human tumor cells and fibroblasts,Proc. Amer. Assoc. Cancer Res. 16:170.
Golub, S. H., Svedmyr, E. A., Hervetson, J. F., Klein, G., and Singh, S., 1972, Cellular reactions against Burkitt lymphoma cells. III. Effector cell activity of leukocytes stimulated in vitro with autoehthonous cultured lymphoma cells, Int. J. Cancer 10:157.
Gomard, E., Duprez, V., Henin, Y., and Levy, J. P., 1976, H-2 region product as determinant in immune cytolysis of syngeneic tumour cells by anti-MSV T lymphocytes, Nature 260:707.
Goodman, H. S., 1961, A general method for thequantitation of immune cytolysis, Nature 190:269.
Gorczynski, R. M., 1976a, Autoreactivity developing spontaneously in cultured mouse spleen cells. I. Evidence that cytotoxicity is directed against embryo associated antigen, Immunology 31:607.
Gorczynski, R. M., 1976b, Autoreactivity developing spontaneously in cultured mouse spleen cells. II. Comparison of cytotoxicity of cultured male and female spleen cells, Immunology 31:615.
Gorczynski, R. M., and Knight, R. A., 1975, Cell mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus induced tumors, Eur. J. Immunol. 5:148.
Gordon, R. D., Simpson, E., and Samelson, L. E., 1975, In vitro cell-mediated immune responses to themale specific (H-V) antigen in mice, J. Exp. Med. 142:1108.
Green, I., 1974, Genetic control of immune responses, Immunogenetics 1:4.
Harris, J. W., MacDonald, H. R., Engers, H. D., Fitch, F. W., and Cerottini, J. C, 1976, Increased cytolytic T lymphocyte activity induced by 2-mercapto-ethanol in mixed leukocyte cultures: Kinetics and possible mechanisms of action, J. Immunol. 116:1071.
Hayry, P., and Defendi, V., 1970, Mixed lymphocyte cultures produce effector cells: Model in vitro for allograft rejection, Science 168:133.
Hayry, P., Anderson, L. C, Nordberg, S., and Virolainen, M., 1972, Allograft response in vitro, Transplant. Rev. 12:91.
Haywood, G. R., and Mackhann, C.F., 1971, Antigenic specificities of murine sarcoma cells. Reciprocal relationship between normal transplantation antigens (H-2) and tumor-specific immunogenicity, J. Exp. Med. 133:1171.
Hellstrom, I., and Hellstrom, K. E., 1976, Specific sensitisation of lymphocytes to tumor antigens by co-cultivation with peritoneal cells exposed to such antigens, Int. J. Cancer 17:748.
Herberman, R. B., Aoki, T., Nunn, M., Lavrin, D. H., Soares, N., Gazdar, A., Holden, H., and Chang, K. S. S., 1974, Specificity of 51Cr release cytotoxicity of lymphocytes immune to murine sarcoma virus, J. Natl. Cancer Inst. 53:1103.
Hyman, R., Ralph, P., and Sarkar, S., 1972, Cell-specific antigens and immunoglobulin synthesis of murine myeloma cells and their variants, J. Natl. Cancer Inst. 48:173.
Ilfeld, D., Carnaud, C, Cohen, I. R., and Trainin, N., 1973, In vitro cytotoxicity and in vivo tumor enhancement induced by mouse spleen cells autosensitised in vitro, Int. J. Cancer 12:213.
Ilfeld, D., Carnaud, C, and Klein, E., 1975, Cytotoxicity of autosensitised lymphocytes restricted to theH-2k end of targets, Immunogenetics 2:231.
Irie, R. F., Irie, K., and Morton, D. L., 1974, Natural antibody to a neoantigen in human cultured cells grown in fetal bovine serum, J. Natl. Cancer Inst. 52:1051.
Johnston, J. M., and Wilson, D. B., 1970, Origin of immunoreactive lymphocytes in rats, Cell. Immunol 1:430.
Kall, M. A., and Hellstrom, I, 1975, Specific stimulatory and cytotoxic effects of lymphocytes sensitised in vitro to either alloantigens or tumor antigens, J. Immunol. 114:1083.
Kall, M. A., Hellstrom, I., and Hellstrom, K. E., 1976, In vitro generation of primary and secondary cytotoxic cell-mediated immune responses to chemically induced mouse sarcomas, Int. J. Cancer 18:488.
Kasakura, S., and Lowerstein, L., 1965, The effect of irradiation in vitro on mixed leukocyte cultures and on leukocyte cultures with phytohaemagglutinin, in: Histocompatibility Testing (H. Bainer, F. J. Cleton, and J, G. Eernisse, eds.), p. 211, Munksgaard, Copenhagen.
Kedar, E., and Bonivida, B., 1975, Studies on theinduction and expression of T cell-mediated immunity. IV. Non-overlapping populations of allo-immune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens, J.Immunol. 115:1301.
Kiessling, R., and Klein, E., 1973, Cytotoxic potential of mouse spleen cells on H-2 antibody treated target cells, J Exp. Med. 137:527.
Kiessling, R., Klein, E., Pross, H., and Wigzell, H., 1975, “Natural” killer cells in themouse. I. Cytotoxic cells with specificity for mouse Moloney leukaemia cells. Specificity and distribution according to genotype, Eur. J. Immunol. 5:112.
Kirchner, H., Glaser, M., Holden, H. T., and Herberman, R. B., 1976, Mixed lymphocyte/ tumor-cell interaction in a murine sarcoma virus (Moloney)-induced tumor system. Comparison between lymphocyte proliferation and lymphocyte cytotoxicity, Int. J. Cancer 17:362.
Klein, G., 1977, Tumor-associated antigens in H-2 hemizygous isoantigenic variants of a somatic cell hybrid derived from fusion of a 3 methylcholanthrene induced sarcoma and a mammary carcinoma, J. Natl. Cancer Inst. 58:383.
Koszinowski, U., and Ertl, H., 1975, Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus, Nature 255:552.
Kuperman, O., Fortner, W., and Lucas, Z. J., 1975a, Immune response to a syngeneic mammary adenocarcinoma. II. In vitro generation of cytotoxic lymphocytes, J. Immunol 115:1277.
Kuperman, O., Fortner, W., and Lucas, Z. J., 1975b, Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity, J. Immunol. 115:1282.
Lamon, E. W., Whitten, H. D., Skurzak, H.M., Andersson, B., and Lidin, B., 1975, IgM antibody-dependent cell-mediated cytotoxicity in theMoloney sarcoma virus system: The involvement of T and B lymphocytes as effector cells, J. Immunol. 115:1288.
Laux, D., and Lausch, R. N., 1974, Reversal of tumor-mediated suppression of immune reactivity by in vitro incubation of spleen cells, J Immunol. 112:1900.
Levy, J. A., Kazan, P., Varmer, O., and Kleinmann, H., 1975, Murine xenotropic type C viruses. I. Distribution and further characterisation of thevirus in NZB mice, J. Virol. 16:844.
Lilly, F., 1970, Fv-2: Identification and location of a second gene governing thespleen focus response to Friend leukaemia virus in mice, J Natl. Cancer Inst. 45:163.
Lilly, F., 1971, The influence of H-2 type on gross virus leukaemogenesis in mice, Transplant. Proc. 3:1239.
Lundak, R. L., and Raidt, O. J., 1973, Cellular immune response against tumor cells. I. In vitro immunisation of allogeneic and syngeneic mouse spleen cell suspensions against DBA mastocytoma cells, Cell. Immunol. 9:60.
Manson, L. A., and Palmer, T. C, 1975, Induction of theimmune response to cell surface antigens in vitro, In Vitro 2:186.
Manson, L. A., Goldstein, L., Thorn, R., and Palmer, J., 1975, Immune response against apparently host-compatible transplantable tumors, Transplant. Proc. 7:161.
Martin-Chandos, M. R., Vanky, F., Carnaud, C., and Klein, E., 1975, In vitro “education” on autologous human sarcoma generated non-specific killer cells, Int. J. Cancer 15:342.
McKhann, C. F., and Jagarlamoody, S. M., 1971,In vitro immunization for immunotherapy, in: Morphological and Fundamental Aspects of Immunity (K. Lindahl-Kiessling, G. Alm, and M. G. Hanna, Jr., eds.), Plenum Press, New York.
Meltzer, M. S., 1976, Tumoricidal responses in vitro of peritoneal macrophages from conventionally housed and germ-free nude mice, Cell. Immunol. 22:176.
Miller, J. F. A. P., Brunner, K.T., Sprent, J., Russell, P. J., and Mitchell, G. F., 1971, Thymus-derived cells as killer cells in cell-mediated immunity, Transplant. Proc. 3:915.
Miller, R. G., and Dunkley, M., 1974, Quantitative analysis of the51Cr release cytotoxicity assay for cytotoxic lymphocytes, Cell. Immunol. 14:284.
Mosier, D., and Cantor, H., 1971, Functional maturation of mouse thymic lymphocytes, Eur. J. Immunol. 1:459.
Nadler, S. H., and Moore, G. E., 1969, Immunotherapy of malignant disease, Arch. Surg. 99:376.
Nakayama, M., Sendo, F., Gotohda, E., Hosokawa, M., Kodama, T., and Kobayasha, H., 1975, Studies of themechanisms of “allogeneic cell immunity” by in vivo neutralisation test, Proc. Jap. Cancer Assoc. 34:59.
Nomoto, K., Mashiba, H., Sato, M., and Takeya, K., 1974, In vitro detection of tumor-specific antigens, GANN Monogr. 16:211.
Nowell, P.C., 1960, Phytohaemagglutinin: An initiator of mitosis in cultures of normal human leukocytes, Cancer Res. 20:462.
Ortiz de Landazuri, M., and Herberman, R. B., 1972a, In vitro activation of cellular immune response to Gross virus-induced lymphoma, J. Exp. Med. 136:969.
Ortiz de Landazuri, M., and Herberman, R. B., 1972b, Specificity of cellular immune reactivity to virus-induced tumors, Nature New Biol. 238:18.
Oth, D., Robert, F., Berebbi, M., and Meyer, G., 1976, Decreased resistance in some heterozygotes in H-2 linked immune response to polyoma induced tumor, Nature 259:316.
Parmiani, G., and Invemizzi, G., 1975, Alien histocompatibility determinants on thecell surface of sarcomas induced by methylcholanthrene. I. In vivo studies, Int. J. Cancer 16:756.
Perlmann, P., 1972, Lymph ocyte cytotoxicity; technical aspects. Introduction, Transplant. Proc. 4:295.
Plata, F., Cerottini, J. C, and Brunner, K. T., 1975, Primary and secondary in vitro generation of cytolytic T lymphocytes in themurine sarcoma virus system, Eur.J. Immunol. 5:227.
Pollack, S., Nelson, K., and Grausz, J. D., 1975, Killer cells from murine spleen: Effectors of antibody-dependent cellular cytotoxicity, Transplant. Proc. 7:477.
Reisfeld, R. A., Pellegrini, M. A., and Kahan, B. D., 1971, Salt extraction of soluble HL-A antigens, Science 172:1134.
Rollinghoff, M., 1974, Secondary cytotoxic tumor immune response induced in vitro, J.Immunol. 112:1718.
Rollinghoff, M., and Wagner, H., 1973, In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibition itin vivo, Eur. J. Immunol. 3:471.
Rollinghoff, M., and Warner, N. L., 1973, Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells, Proc. Soc. Exp. Biol. Med. 144:813.
Sanderson, C. J., 1976a, The mechanism of T cell mediated cytotoxicity. I. The release of different cell components, Proc. Roy. Soc. Lond. B192:221.
Sanderson, C. J., 1976b, The mechanism of T cell mediated cytotoxicity. II. Morphological studies of cell death by time-lapse micro-cinematography, Proc. Roy. Soc. London. 192:241.
Sato, H., Boyse, E. A., Aoki, T., Iritani, C., and Old, L.J., 1973, Leukaemia-associated transplantation antigens related to murine leukaemia virus. The X-1 system: Immune response controlled by a locus linked to H-2, J. Exp. Med. 138:593.
Schneider, E. L., Steinbridge, E. J., and Epstein, C. J., 1974, Incorporation of 3H-uridine and 3H-uracil into RNA: A simple technique for thedetection of mycoplasma contamination of cultured cells, Exp. Cell. Res. 84:311.
Schrader, J. W., and Edelman, G. M., 1976, Participation of the H-2 antigens of tumor cells in their lysis by syngeneic T cells, J. Exp. Med. 143:601.
Schrek, R., and Donnelly, W. J., 1961, Differences between lymphocytes of leukemic and non-leukemic patients with respect to morphologic features, mobility, and sensitivity to guinea pig serum, Blood 18:561.
Scigler, H. F., Shingleton, W. W., Metzgar, R. S., Buckley, C. E., Bergoe, P. M., Miller, D. S., Fetter, B. F., and Phaup, M. B., 1972, Non-specific and specific immunotherapy in patients with melanoma, Surgery 72:162.
Senik, A., Hebrero, P., and Levy, J. P., 1975, Secondary specific immune response in vitro to MSV tumor cells, Int. J. Cancer 16:946.
Sharma, B., and Terasaki, P. I., 1974, In vitro immunisation to cultured human tumor cells, Cancer Res. 34:115.
Shearer, G., 1974, Cell mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes, Eur. J. Immunol 4:527.
Shearer, G. M., Rehn, T. G., and Garbarino, C. A., 1975, Cell mediated lympholysis of trinitrophenyl modified autologous lymphocytes. Effector cell specificity to modified cell surface components by theH-2K and H-2D serological regions of themurine major histocompatibility complex, J. Exp. Med. 141:1348.
Shellam, G. R., 1974, Studies on a Gross-virus-induced lymphoma in therat. I. The cell mediated immune response, Int. J. Cancer 14:65.
Shreffler, D., and David, C., 1975, H-2 major histocompatibility complex and immune response region-genetic variation, function and organization, Adv. Immunol. 20:125.
Shustik, C., Cohen, I. R., Schwartz, R. C., Latham-Griffin, E., and Waksal, S. D., 1976, T cells with promiscuous cytotoxicity, Nature 263:701.
Small, M., and Trainin, N., 1975, Inhibition of syngeneic fibrosarcoma growth by lymphocytes sensitised on tumor cell monolayers in thepresence of thethymic humoral factor, Int. J. Cancer 15:962.
Solliday, S., and Bach, F. H., 1970, Cytotoxicity: Specificity after in vitro sensitisation, Science 170:1406.
Stout, R. D., Waksal, S. D., and Herzenberg, L. A., 1976, Fc receptor on thymus derived lymphocytes. 3. Mixed lymphocyte reactivity and cell mediated lympholytic activity of Fc+ and Fc−lymphocytes, J. Exp. Med. 144:54.
Sulit, H. L., Golub, S. H., Reiko, F. I., Gupta, R. K., Crooms, G. A., and Morton, D. L., 1976, Human tumor cells grown in fetal calf serum and human serum; influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects, Int. J. Cancer 17:461.
Takasugi, M., and Klein, E. A., 1970, A microassay for cell-mediated immunity, Transplantation 9:219.
Takasugi, M., and Terasaki, P., 1973, Quantitation of themicroassay for cell-mediated immunity through electronic image analysis, Natl. Cancer Inst. Monogr. 37:77.
Takasugi, M., Akira, D., and Kinoshita, K., 1975, Granulocytes as effectors in cell-mediated cytotoxicity of adherent target cells, Cancer Res. 35:2169.
Takei, F., Levy, J. G., and Kilburn, D. G., 1976, In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice, J. Immunol. 116:288.
Thorn, R. M., Palmer, J. C, and Manson, L. A., 1974, A simplified 51Cr release assay for killer cells, J. Immunol. Methods 4:301.
Ting, C. C., and Bonnard, G. D., 1976, Cell-mediated immunity to Friend virus induced leukaemia. IV. In vitro generation of primary and secondary cell-mediated cytotoxic responses, J. Immunol. 116:1419.
Ting, C. C., and Herberman, R. B., 1971, Inverse relationship of polyoma tumour specific antigens and H-2 histocompatibility antigens, Nature New Biol. 232:118.
Ting, C. C., and Law, L. W., 1977, Studies of H-2 restriction in cell-mediated cytotoxicity and transplantation immunity to leukaemia-associated antigens, J. Immunol. 118:1259.
Treves, A. J., Cohen, I. R., and Feldman, M., 1975, Immunotherapy of lethal métastases by lymphocytes sensitised against tumor cells in vitro, J. Natl. Cancer Inst 54:777.
Treves, A. J., Schechter, B., Cohen, I. R., and Feldman, M., 1976, Sensitisation of T lymphocytes in vitro by syngeneic macrophages fed with tumor antigens, J. Immunol. 116:1059.
Trinchieri, G., Aden, D. P., and Knowles, B. B., 1976, Cell mediated cytotoxicity to SV40-specific tumour associated antigens, Nature 261:313.
Trostmann, H., Pfizenmaier, R., Wagner, H., and Rollinghoff, M., 1976, Cell-mediated immunity to H-2 antigens. Characteristics of theeffector cells detected in themicro-cytotoxicity assay, Transplantation 21:446.
Van Loveren, H., and den Otter, W., 1974, In vitro activation of armed macrophages and the therapeutic application in mice, J. Natl. Cancer Inst. 51:1917.
Vasudevan, D.M., Brunner, K. T., and Cerottini, J.C., 1973, Increased cytotoxic effect of immune lymphocytes in a syngeneic tumor system following simple purification procedures, Brit. J. Cancer 28 (Suppl. I): 35.
Wagner, H., and Rollinghoff, M., 1973, In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunised in vitro against syngeneic and allogeneic plasma cell tumors, J. Exp. Med. 138:1.
Wagner, EL, Harris, A., and Feldmann, M., 1972, Cell-mediated immune response in vitro. II. The role of thymus and thymus-derived lymphocytes, Cell. Immunol. 4:39.
Wagner, H., Rollinghoff, M., and Nossal, G. J., 1973, T-cell-mediated immune responses induced in vitro: A probe for allograft and tumor immunity, Transplant. Rev. 17:3.
Wagner, H., Hess, M., Feldmann, M., and Rollinghoff, M., 1976, Secondary cytotoxic allograft responses in vitro. III. The immunogenicity of allogeneic membrane fragments, Transplantation 21:282.
Wainberg, M. A., Markson, Y., Weiss, D.W., and Doljanski, F., 1974, Cellular immunity against Rous sarcomas of chickens. Preferential reactivity against autochthonous target cells as determined by lymphocyte adherence and cytotoxicity tests in vitro, Proc. Natl. Acad. Sci. U.S. 71:3365.
Warnatz, F., Scheiffarth, F., and Schmeissner, R., 1975, Studies on thecytotoxic effect of in vivo and in vitro immunised lymphocytes on liver target cells, Clin. Exp. Immunol. 21:250.
Warnatz, H., and Scheiffarth, F., 1974, Cell-mediated immune response of in vitro sensitised lymphocytes to isogeneic methyl-cholanthrene induced tumor cell Unes, Transplantation 18:273.
Wigzell, H., 1965, Quantitative titrations of mouse H-2 antibodies using 51Cr labelled target cells, Transplantation 3:423.
Winn, H. J., 1961, Immune mechanisms in homotransplantation. II. Quantitative assay of theimmunologic activity of lymphoid cells stimulated by tumor homografts, J. Immunol. 86:228.
Wunderlich, J. R., and Canty, T. G., 1970, Cell mediated immunity induced in vitro. Nature 228:63.
Zarling, J. M., Raich, P. C, Mckeogh, M., and Bach, F. H., 1976, Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells, Nature 262:691.
Zinkernagel, R. M., 1974, Restriction by H-2 gene complex of transfer of cell mediated immunity to Listeria monocytogenes, Nature 251:230.
Zinkernagel, R. M., and Doherty, P. C, 1974, Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis, Nature 251:547.
Zinkernagel, R. M., and Doherty, P.C., 1975, H-2 compatibility requirement for T-cell mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic-T cell specificities are associated with strictures coded for on H-2K or H-2D, J. Exp.Med. 141:1427.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Plenum Press, New York
About this chapter
Cite this chapter
Burton, R.C., Chism, S.E., Warner, N.L. (1978). In Vitro Induction and Expression of T-Cell Immunity to Tumor-Associated Antigens. In: Warner, N.L., Cooper, M.D., Hanna, M.G. (eds) Contemporary Topics in Immunobiology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-0922-2_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-0922-2_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-0924-6
Online ISBN: 978-1-4684-0922-2
eBook Packages: Springer Book Archive